Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Almohanad A Alkayyal

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Neoantigen-Encoded Oncolytic Viruses as Personalized Cancer VaccinesAlmohanad A Alkayyal
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
A 5-Year Update on the Clinical Development of Cancer Cell-Based Vaccines for Glioblastoma MultiformeAlmohanad A Alkayyal, Ahmad Bakur Mahmoud
Anticancer Research|August 28, 2025
Identification of Small Molecule Inhibitors Targeting PD-L1 Protein Using Computational Tools and an Experimental AssayShymaa Damfo, Almohanad A Alkayyal, Ahmad Bakur Mahmoud
Journal of Epidemiology and Global Health|February 19, 2021
The Recombination Potential between SARS-CoV-2 and MERS-CoV from Cross-Species Spill-over InfectionsAbdulrahim A Sajini, Almohanad A Alkayyal, Fathi A Mubaraki
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|August 1, 2025
Immunogenic mutanome of breast cancer: Advances, challenges and future directions in neoantigen-based immunotherapyAlmohanad A Alkayyal, Niza H Saeedi, Mamdouh S Moawadh
Frontiers in Immunology|January 23, 2023
Remodeling the tumor immune microenvironment with oncolytic viruses expressing miRNAsGuillaume St-Cyr, Daphné Penarroya, Lauren Daniel, et al.
Frontiers in Immunology|March 2, 2023
Heterologous prime-boost cellular vaccination induces potent antitumor immunity against triple negative breast cancerSeyedeh-Raheleh Niavarani, Guillaume St-Cyr, Lauren Daniel, et al.
Frontiers in Oncology|March 6, 2023
Perioperative oncolytic virotherapy to counteract surgery-induced immunosuppression and improve outcomes in pancreatic ductal adenocarcinomaSarah Mansouri, Lauren Daniel, Nawal Amhis, et al.
Journal of Visualized Experiments : Jove|April 2, 2014
A mouse tumor model of surgical stress to explore the mechanisms of postoperative immunosuppression and evaluate novel perioperative immunotherapiesLee-Hwa Tai, Christiano Tanese de Souza, Shalini Sahi, et al.
Frontiers in Immunology|October 31, 2022
Advances in immunotherapy for glioblastoma multiformeAhmad Bakur Mahmoud, Reham Ajina, Sarah Aref, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Neoantigen-Encoded Oncolytic Viruses as Personalized Cancer VaccinesAlmohanad A Alkayyal
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
A 5-Year Update on the Clinical Development of Cancer Cell-Based Vaccines for Glioblastoma MultiformeAlmohanad A Alkayyal, Ahmad Bakur Mahmoud
Anticancer Research|August 28, 2025
Identification of Small Molecule Inhibitors Targeting PD-L1 Protein Using Computational Tools and an Experimental AssayShymaa Damfo, Almohanad A Alkayyal, Ahmad Bakur Mahmoud
Journal of Epidemiology and Global Health|February 19, 2021
The Recombination Potential between SARS-CoV-2 and MERS-CoV from Cross-Species Spill-over InfectionsAbdulrahim A Sajini, Almohanad A Alkayyal, Fathi A Mubaraki
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|August 1, 2025
Immunogenic mutanome of breast cancer: Advances, challenges and future directions in neoantigen-based immunotherapyAlmohanad A Alkayyal, Niza H Saeedi, Mamdouh S Moawadh
Frontiers in Immunology|January 23, 2023
Remodeling the tumor immune microenvironment with oncolytic viruses expressing miRNAsGuillaume St-Cyr, Daphné Penarroya, Lauren Daniel, et al.
Frontiers in Immunology|March 2, 2023
Heterologous prime-boost cellular vaccination induces potent antitumor immunity against triple negative breast cancerSeyedeh-Raheleh Niavarani, Guillaume St-Cyr, Lauren Daniel, et al.
Frontiers in Oncology|March 6, 2023
Perioperative oncolytic virotherapy to counteract surgery-induced immunosuppression and improve outcomes in pancreatic ductal adenocarcinomaSarah Mansouri, Lauren Daniel, Nawal Amhis, et al.
Journal of Visualized Experiments : Jove|April 2, 2014
A mouse tumor model of surgical stress to explore the mechanisms of postoperative immunosuppression and evaluate novel perioperative immunotherapiesLee-Hwa Tai, Christiano Tanese de Souza, Shalini Sahi, et al.
Frontiers in Immunology|October 31, 2022
Advances in immunotherapy for glioblastoma multiformeAhmad Bakur Mahmoud, Reham Ajina, Sarah Aref, et al.
Pageof 4